Impact of ideal body weight dosing for all inpatient i.v. immune globulin indications

American Journal of Health-System Pharmacy

Volumn 70, Issue 9, 2013, Pages 751-752

  Rocchio, Megan A ^a   Hussey, Aaron P ^a   Southard, Robert A ^a   Szumita, Paul M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

BODY WEIGHT; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG HALF LIFE; HOSPITAL PATIENT; HUMAN; IMMUNOTHERAPY; LETTER; MAJOR CLINICAL STUDY; PRACTICE GUIDELINE; TOTAL QUALITY MANAGEMENT; TREATMENT INDICATION; VOLUME OF DISTRIBUTION; DOSE RESPONSE; DRUG EFFECTS; HOSPITALIZATION; IDEAL BODY WEIGHT; METABOLISM; PHYSIOLOGY; PROSPECTIVE STUDY;

DOSE-RESPONSE RELATIONSHIP, DRUG; HOSPITALIZATION; HUMANS; IDEAL BODY WEIGHT; IMMUNOGLOBULINS, INTRAVENOUS; PROSPECTIVE STUDIES;

EID: 84892598424     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/ajhp110744     Document Type: Letter

References (8)

1. Orange JS, Hossny EM, Weiler CR et al. Use of intravenous immunoglobulin in human disease: a review of evidence by members of the Primary Immunodeficiency Committee of the American Academy of Allergy, Asthma and Immunology. J Allergy Clin Immunol. 2006; 117(suppl):S525-53.
2. Ballow M. Clinical and investigational considerations for the use of IGIV therapy. Am J Health-Syst Pharm. 2005; 62(suppl 3):S12-8.
3. Leong H, Stachnik J, Bonk ME et al. Unlabeled uses of intravenous immune globulin. Am J Health-Syst Pharm. 2008; 65:1815-24.
4. Shah S. Pharmacy considerations for the use of IGIV therapy. Am J Health-Syst Pharm. 2005; 62(suppl 3):S5-11.
5. Kirschenbaum B, Riedl M, Huff C. Maximizing efficiencies and economic benefits of IVIG. www.pharmacy practicenews.com/download/SR0956-IVIG-CSLB-WM.pdf (accessed 2013 Feb 25).
6. Koleba T, Ensom MH. Pharmacokinetics of intravenous immunoglobulin: a systematic review. Pharmacotherapy. 2006; 26:813-27.
7. Siegel J. Immunoglobulins and obesity. www.pharmacypracticenews.com/ViewArticle.aspx?d=IVIG+FAQs&d-id=401&i=January+2010&i-id=597&a-id=14546 (accessed 2013 Feb 25).
8. Proven D, Nokes TJ, Agrawal S et al. Clinical guidelines for the use of intravenous immunoglobulin. London: Department of Health; 2008.